Showing results (181-190 of 262) with videos related to
Sort By:
Pageof 27
The Journal of Pathology|December 6, 2017
Donor-derived, metastatic urothelial cancer after kidney transplantation associated with a potentially oncogenic BK polyomavirusDavid C Müller, Maarit Rämö, Klaudia Naegele, et al.Endocrine-Related Cancer|June 19, 2014
MED12 overexpression is a frequent event in castration-resistant prostate cancerDavid Adler, Anne Offermann, Martin Braun, et al.The Journal of Pathology|May 2, 2021
Prostate cancer patient-derived organoids: detailed outcome from a prospective cohort of 81 clinical specimensRaphaëlle Servant, Michele Garioni, Tatjana Vlajnic, et al.Lung Cancer (Amsterdam, Netherlands)|November 6, 2012
VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: pooled analysis of SAKK19/05 and NTR528Oliver Gautschi, Anne-Marie Dingemans, Susanne Crowe, et al.Lung Cancer (Amsterdam, Netherlands)|September 27, 2012
Bevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB/IV) followed by platinum-based chemotherapy (CT) at disease progression: a multicenter phase II trial (SAKK 19/05)Francesco Zappa, Cornelia Droege, Daniel Betticher, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 18, 2010
ERG rearrangement is specific to prostate cancer and does not occur in any other common tumorVeit J Scheble, Martin Braun, Rameen Beroukhim, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 25, 2022
NSCLC Subtyping in Conventional Cytology: Results of the International Association for the Study of Lung Cancer Cytology Working Group Survey to Determine Specific Cytomorphologic Criteria for Adenocarcinoma and Squamous Cell CarcinomaDeepali Jain, Aruna Nambirajan, Gang Chen, et al.European Journal of Nuclear Medicine and Molecular Imaging|August 20, 2016
The prognostic and predictive value of sstr2-immunohistochemistry and sstr2-targeted imaging in neuroendocrine tumorsPhilippe Brunner, Ann-Catherine Jörg, Katharina Glatz, et al.Virchows Archiv : an International Journal of Pathology|May 26, 2019
PD-L1 testing of non-small cell lung cancer using different antibodies and platforms: a Swiss cross-validation studySpasenija Savic, Sabina Berezowska, Serenella Eppenberger-Castori, et al.Lung Cancer (Amsterdam, Netherlands)|December 19, 2022
Assessment of RANK/RANK-L prevalence and clinical significance in NSCLC European Thoracic Oncology Platform Lungscape cohort and SPLENDOUR randomized clinical trialSolange Peters, Igor Letovanec, Murielle Mauer, et al.Pageof 27